Concepedia

Tarik Dabdoubi

TD

5

Publications

391

Citations

5

H-Index

2015

Active since

Affiliations

Sanofi (France)(Current)

Tarik Dabdoubi is an author at Sanofi (France) specializing in radiation oncology, tumor microenvironment, and immunology.

Top concepts

Publications per year

2015–2020

5

Publications

5

Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulation

Lan Wu, Edward Seung, Ling Xu et al. · Nature Cancer · 2019 · 232 citations

, , +8

Preclinical Activity of SAR408701: A Novel Anti-CEACAM5–maytansinoid Antibody–drug Conjugate for the Treatment of CEACAM5-positive Epithelial Tumors

Stéphanie Decary, Pierre‐François Berne, Céline Nicolazzi et al. · Clinical Cancer Research · 2020 · 74 citations · Full text

Intracellular delivery of therapeutic antibodies into specific cells using antibody-peptide fusions

Julie Gaston, Nicolas Maestrali, Guilhem Lalle et al. · Scientific Reports · 2019 · 65 citations · Full text

Abstract 1688: A novel anti-CEACAM5 maytansinoid-antibody-drug conjugate for the treatment of colorectal, lung and gastric tumors

Stéphanie Decary, Pierre‐François Berne, Céline Nicolazzi et al. · Cancer Research · 2015 · 10 citations

, , +21

Complementary epitopes and favorable developability of monoclonal anti-LAMP1 antibodies generated using two transgenic animal platforms

Béatrice Cameron, Tarik Dabdoubi, Laurence Berthou-Soulié et al. · PLoS ONE · 2020 · 10 citations · Full text

Rows per page

1–5 of 5